Cargando…
Development of Antibody Therapeutics against Flaviviruses
Recent outbreaks of Zika virus (ZIKV) highlight the urgent need to develop efficacious interventions against flaviviruses, many of which cause devastating epidemics around the world. Monoclonal antibodies (mAb) have been at the forefront of treatment for cancer and a wide array of other diseases due...
Autores principales: | Sun, Haiyan, Chen, Qiang, Lai, Huafang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796004/ https://www.ncbi.nlm.nih.gov/pubmed/29295568 http://dx.doi.org/10.3390/ijms19010054 |
Ejemplares similares
-
Flavivirus: From Structure to Therapeutics Development
por: Zhao, Rong, et al.
Publicado: (2021) -
Antibody-Dependent Enhancement Activity of a Plant-Made Vaccine against West Nile Virus
por: Sun, Haiyan, et al.
Publicado: (2023) -
mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021) -
Mosquito-Borne Flaviviruses and Current Therapeutic Advances
por: Qian, Xijing, et al.
Publicado: (2022) -
Recent Developments in Vaccines against Flaviviruses and Alphaviruses
por: Kim, Young Chan, et al.
Publicado: (2023)